About us

Science-Driven Therapeutic Innovation

The Lo.Li. Pharma Group researches and develops therapeutic Food Supplements and Medical Devices, with a focus on the fields of gynecology, fertility, endocrinology, and recently respiratory, cardiology and neuropsychiatry.

2001

Group Foundation

Lo.Li. Pharma was founded with the goal of developing and distributing products dedicated to women’s healthcare in Italy.

2009

International Expansion

Lo.Li. Pharma started its first international activities, cooperating with companies in South Africa, Bulgaria, and other countries.

2012

Lo.Li. Pharma International

The fast growth of global partnerships led to the founding of Lo.Li. Pharma International, a company fully dedicated to international markets.

2023

Lo.Li Pharma USA

To reinforce its foothold in the United States, Lo.Li. Pharma founded Lo.Li. Pharma USA, with the goal of expanding market presence and exploring new strategic business opportunities.

2025

Presence in 60+ Countries

Lo.Li.’s products are now available in more than 60 countries around the world.

2026

Lo.Li Therapeutics was launched to strengthen and expand the company’s portfolio across its three strategic therapeutic areas: respiratory, cardiology and neuropsychiatry.

Advancing Therapeutic Focus

Lo.Li. Pharma Therapeutics

When focus becomes a strategic choice Portfolio growth and increasing complexity made sustained focus and long-term scientific commitment essential.

This maturity led to a strategic decision: The creation of a specialized division dedicated to selected therapeutic areas operating with greater depth and clarity.

Lo.Li. Pharma Therapeutics was created to concentrate expertise and resources where depth and long-term commitment are essential. It represents the evolution of a proven model, designed to deliver greater specialization and strategic clarity.

A structure built

around our Partners

Our integrated structure supports every stage of the partnership, from market access to long-term growth.

Business Development

The Business Development Team aims to expand global patient access to new treat- ments by ensuring the most profitable opportunities for our future partners.

Legal Office

A multi-specialized team is dedicated to protecting our intellectual property rights and safeguarding our Partners’ competitive edge.

Regulatory and quality

R&Q guides product registration according to country requirements, supporting market access. They also ensure a consistent supply of high quality products.

Medical Marketing

We provide high-quality, scientifically supported marketing materials, field-based knowledge, and competitive insights. Our marketing team is constantly working with our Partners to share experiences and help them reach their goals.

Account Management

Serving as our Partners’ extended team, account managers respond to every query, monitor sales performance, and take immediate action to resolve any issues that may arise. They identify new business opportunities and develop our Partners’ portfolio, throughout our long-term partnership.

Logistics

A large team is highly involved in logistical support: from the purchasing and shipping of goods to monitoring forecasts. They ensure prompt and consistent availability of the products according to market demand.

From Myo-inositol

science to targeted therapeutic solutions

For over 25 years, Lo.Li. Pharma has been advancing myo-inositol research, contributing to its clinical application starting from PCOS.

This expertise has evolved into a precise approach to therapy development, where formulation plays a key role in addressing specific clinical needs.

Today, myo-inositol remains the foundation of our solutions, applied across multiple therapeutic areas through targeted, evidence-based formulations.

Follow Us On LinkedIn

About Us